AU2002248792A1 - A novel coating for a sustained release pharmaceutical composition - Google Patents

A novel coating for a sustained release pharmaceutical composition

Info

Publication number
AU2002248792A1
AU2002248792A1 AU2002248792A AU2002248792A AU2002248792A1 AU 2002248792 A1 AU2002248792 A1 AU 2002248792A1 AU 2002248792 A AU2002248792 A AU 2002248792A AU 2002248792 A AU2002248792 A AU 2002248792A AU 2002248792 A1 AU2002248792 A1 AU 2002248792A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
sustained release
release pharmaceutical
novel coating
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002248792A
Other versions
AU2002248792B2 (en
Inventor
Nirmal Mulye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nostrum Pharmaceuticals Inc
Original Assignee
Nostrum Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US28446301P priority Critical
Priority to US60/284,463 priority
Application filed by Nostrum Pharmaceuticals Inc filed Critical Nostrum Pharmaceuticals Inc
Priority to PCT/US2002/012140 priority patent/WO2002085335A1/en
Publication of AU2002248792A1 publication Critical patent/AU2002248792A1/en
Application granted granted Critical
Publication of AU2002248792B2 publication Critical patent/AU2002248792B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2002248792A 2001-04-18 2002-04-18 A novel coating for a sustained release pharmaceutical composition Ceased AU2002248792B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US28446301P true 2001-04-18 2001-04-18
US60/284,463 2001-04-18
PCT/US2002/012140 WO2002085335A1 (en) 2001-04-18 2002-04-18 A novel coating for a sustained release pharmaceutical composition

Publications (2)

Publication Number Publication Date
AU2002248792A1 true AU2002248792A1 (en) 2003-04-17
AU2002248792B2 AU2002248792B2 (en) 2006-09-21

Family

ID=23090316

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002248792A Ceased AU2002248792B2 (en) 2001-04-18 2002-04-18 A novel coating for a sustained release pharmaceutical composition

Country Status (8)

Country Link
US (1) US6946146B2 (en)
EP (1) EP1385486A4 (en)
JP (1) JP2004530676A (en)
AU (1) AU2002248792B2 (en)
CA (1) CA2444569C (en)
MX (1) MXPA03009588A (en)
NZ (1) NZ528957A (en)
WO (1) WO2002085335A1 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
FR2822834B1 (en) * 2001-04-02 2005-02-25 Flamel Tech Sa Colloidal suspension of nanoparticles based on amphiphilic copolymers for vectorization of active ingredients and their method of preparation
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
DE60323474D1 (en) 2002-04-09 2008-10-23 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension of micro-capsules for the modified release of amoxicillin
CN100553625C (en) 2002-04-09 2009-10-28 弗拉梅技术公司 The oral administration mixed suspension of active principle microcapsules
FR2842735B1 (en) * 2002-07-26 2006-01-06 Flamel Tech Sa Modified release microcapsules of low soluble active principles for per os administration
FR2842736B1 (en) * 2002-07-26 2005-07-22 Flamel Tech Sa Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of low soluble active (s) principle (s)
FR2843117B1 (en) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacids functionalized by at least one hydrophobic group and their particularly therapeutic applications
JP2006520390A (en) * 2003-03-14 2006-09-07 ムルイェ、ニルマル Method for producing sustained-release tablets
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
PT1502587E (en) * 2003-07-30 2007-01-31 Pharmathen Sa Sustained release formulation for venlafaxine hydrochloride
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
FR2860516B1 (en) * 2003-10-03 2006-01-13 Flamel Tech Sa Telechelic homopolyaminoacides functionalized by hydrophobic groups and their particularly therapeutic applications
JPWO2005039542A1 (en) * 2003-10-27 2007-02-15 アステラス製薬株式会社 Drug-containing coated microparticles for orally disintegrating tablets
US20050175689A1 (en) * 2003-10-27 2005-08-11 Yamanouchi Pharmaceutical Co., Ltd. Coated fine particles containing drug for intrabuccally fast disintegrating tablet
FR2862536B1 (en) * 2003-11-21 2007-11-23 Flamel Tech Sa Pharmaceutical formulations for the prolonged delivery of active (s) principle (s) and their particularly therapeutic applications
DE10358747A1 (en) * 2003-12-12 2005-07-07 Lts Lohmann Therapie-Systeme Ag Dosage form based on crosslinked hydrophilic polymers
BRPI0418283A (en) * 2004-02-04 2007-05-02 Alembic Ltd prolonged release formulation and process for preparing an extended release formulation
EP1722758A1 (en) * 2004-02-11 2006-11-22 Athpharma Limited Chronotherapeutic compositions and methods of their use
CA2561167C (en) * 2004-03-25 2012-09-11 Astellas Pharma Inc. Composition of solifenacin or salt thereof for use in solid formulation
TW200534879A (en) * 2004-03-25 2005-11-01 Squibb Bristol Myers Co Coated tablet formulation and method
US7829720B2 (en) 2004-05-04 2010-11-09 Bristol-Myers Squibb Company Process for preparing atazanavir bisulfate and novel forms
TWI354569B (en) 2004-05-28 2011-12-21 Squibb Bristol Myers Co Coated tablet formulation and method
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
JP2008525313A (en) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 Anti-dementia drug stabilization method
WO2006070735A1 (en) * 2004-12-27 2006-07-06 Astellas Pharma Inc. Stable granular pharmaceutical composition of solifenacin or its salt
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Break-resistant dosage forms with sustained release
DE102005005449A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Process for producing an anti-abuse dosage form
EP1868587A2 (en) * 2005-04-08 2007-12-26 Abbott Laboratories Pharmaceutical formulations comprising fenofibric acid and/or its salts
FR2885526B1 (en) * 2005-05-13 2007-07-27 Flamel Technologies Sa Oral medicine based on proton pump inhibitor
US7815939B2 (en) * 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
JP5649784B2 (en) * 2006-02-07 2015-01-07 エフ エム シー コーポレーションFmc Corporation Composition, method for coating substrate with composition, coated substrate, product, film, pellet, tablet and capsule
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
CA2648280C (en) 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US20070264335A1 (en) * 2006-05-09 2007-11-15 Sherman Bernard C Modified release tablets comprising tramadol
US20140010860A1 (en) 2006-05-12 2014-01-09 Isa Odidi Abuse and alcohol resistant drug composition
KR100774613B1 (en) * 2006-05-26 2007-11-12 한국화학연구원 Sustained release drug delivery system composed of water insoluble polymer
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
EP2046299A1 (en) * 2006-07-11 2009-04-15 Mutual Pharmaceutical Company, Inc. Controlled-release formulations
US20080131563A1 (en) * 2006-11-30 2008-06-05 Vladek Kasperchik Food-compatible laser-imageable coatings
TWI405574B (en) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd Pharmaceutical solid preparation and production method thereof
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
ME01026B (en) 2007-11-16 2012-10-20 Univ Rockefeller Antibodies specific for the protofibril form of beta-amyloid protein
US20090169622A1 (en) * 2007-12-27 2009-07-02 Roxane Laboratories, Inc. Delayed-release oral pharmaceutical composition for treatment of colonic disorders
MX2010010214A (en) 2008-03-20 2010-12-21 Virun Inc Vitamin e derivatives and their uses.
DK2268160T3 (en) 2008-03-20 2013-01-07 Virun Inc Emulsions comprising a PEG derivative of tocopherol
WO2010083360A2 (en) * 2009-01-16 2010-07-22 Mutual Pharmaceutical Company, Inc. Controlled-release formulations
EP2398469A4 (en) * 2009-02-23 2013-09-04 Aptalis Pharmatech Inc Controlled release compositions comprising anti-cholinergic drugs
US20100260842A1 (en) * 2009-04-06 2010-10-14 Rashmi Nair Pseudoephedrine pharmaceutical formulations
AR077420A1 (en) 2009-07-22 2011-08-24 Gruenenthal Gmbh Dosage form resistant to manipulation for oxidation sensitive opioids
EP2563164B1 (en) * 2010-03-23 2016-06-29 Virun, Inc. Nanoemulsion including sucrose fatty acid ester
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
RU2606588C2 (en) * 2011-06-17 2017-01-10 Эвоник Рем ГмбХ Coating composition suitable for pharmaceutical or nutriceutical dosage forms
HUE034710T2 (en) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US20130345338A1 (en) * 2012-06-25 2013-12-26 Michael R. Hoggatt System and method for treating agricultural settings
US20150250734A1 (en) 2012-12-21 2015-09-10 Wockhardt Limited Stable pharmaceutical compositions of saxagliptin or salts thereof
WO2014096983A1 (en) 2012-12-21 2014-06-26 Wockhardt Limited Stable pharmaceutical compositions of saxagliptin or salts thereof
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
CN105682643B (en) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 Tamper resistant dosage form containing ethylene-vinyl acetate polymer
AU2014321277B2 (en) 2013-09-19 2017-07-20 Terumo Corporation Polymer particles
CA2923741A1 (en) 2013-09-19 2015-03-26 Microvention, Inc. Polymer films
KR20160084846A (en) 2013-11-08 2016-07-14 테루모 가부시키가이샤 Polymer particles
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
KR20170086063A (en) * 2014-11-19 2017-07-25 바이오젠 엠에이 인코포레이티드 Pharmaceutical bead formulations comprising dimethyl fumarate
US9907880B2 (en) 2015-03-26 2018-03-06 Microvention, Inc. Particles
US20200140527A1 (en) 2016-08-31 2020-05-07 University Of Rochester Human Monoclonal Antibodies to Human Endogenous Retrovirus K Envelope (HERV-K) and Use Thereof
CN109789239A (en) 2016-09-28 2019-05-21 泰尔茂株式会社 Polymer beads
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
IL88083A (en) 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
FR2698560B1 (en) * 1992-11-30 1995-02-03 Virbac Laboratoires Stabilized powdery active ingredients, compositions containing them, process for obtaining them and their applications.
PT758244E (en) * 1994-05-06 2002-04-29 Pfizer Dosage forms controlled freedom of azithromycin
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
HU0002296A3 (en) * 1997-07-01 2001-11-28 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
CA2354057C (en) * 1998-12-11 2009-02-10 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US6251432B1 (en) * 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same

Similar Documents

Publication Publication Date Title
AU2002307151A1 (en) A process for the preparation of nanostructured materials
EP1383376A4 (en) Pharmaceutical formulations for sustained release
AU2002342196A1 (en) A medicine dispenser
AU2002333520A1 (en) Compositions comprising photo-labile
AU2003250210A1 (en) A dispenser
AU2002341567A1 (en) Improved stent coating
AU2002220906A1 (en) Drug dispenser
AU2002340918A1 (en) Herbicidal composition
AU2002316539A1 (en) CD10-activated prodrug compounds
AUPR748801A0 (en) A stent
AU2002349297A1 (en) Statin-like compounds
AU2002354224A1 (en) Novel phenylalanine derivative
AU2002323381A1 (en) Deodorant composition
AUPR682201A0 (en) Glyphosate composition
AU2002325065A1 (en) Glyphosate composition
AU2003218151A1 (en) Slow release nitrogen coating
AU2001267479A1 (en) Sprayable coating composition
AU2002311833A1 (en) Spiropyrazole compounds
AU2002245729A1 (en) Easy loading dispenser
AU2002355245A1 (en) Novel compounds
AU2002339268A1 (en) Novel pyrrole derivatives as pharmaceutical agents
AU2002365120A1 (en) Medicaments
AU781269C (en) Pharmaceutical compositions
AU2002367404A1 (en) Redox-switchable materials
AU2002310520A1 (en) Dispenser for wipes